<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-22041" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Gallstones (Cholelithiasis)</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Jones</surname>
            <given-names>Mark W.</given-names>
          </name>
          <aff>McLaren Greater Lansing, MSUCOM</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Weir</surname>
            <given-names>Connor B.</given-names>
          </name>
          <aff>Michigan State University/Mclaren</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ghassemzadeh</surname>
            <given-names>Sassan</given-names>
          </name>
          <aff>Riverside Comm Hosp, UC Riverside</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Mark Jones declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Connor Weir declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Sassan Ghassemzadeh declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>17</day>
          <month>8</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-22041.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Gallstones are crystallized deposits in the gallbladder or within the biliary tree, composed of cholesterol, bilirubin, and bile. Although often asymptomatic and discovered incidentally, gallstones can cause right upper abdominal pain, nausea, vomiting, obstruction, cholangitis, and pancreatitis, especially after consuming greasy or spicy foods.</p>
        <p>This activity focuses on evaluating and managing gallstones, a leading cause of gastrointestinal disorders in the United States. In addition, it reviews diagnostic modalities, treatment options, and interprofessional approaches essential for treating individuals with gallstones. Through this activity, healthcare professionals enhance their competence in identifying and managing gallstone-related complications, improving patient outcomes and quality of care.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the pathophysiology and risk factors&#x000a0;associated with&#x000a0;gallstone formation.</p></list-item><list-item><p>Differentiate between symptomatic and asymptomatic gallstones and their potential complications.</p></list-item><list-item><p>Implement evidence-based treatment strategies for managing symptomatic gallstones, including laparoscopic cholecystectomy and endoscopic retrograde cholangiopancreatography.</p></list-item><list-item><p>Collaborate with interprofessional teams to optimize patient care and treatment strategy for gallstones.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=22041&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=22041">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-22041.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Gallstones are among the most common causes of gastrointestinal dysfunction in the United States&#x000a0;and worldwide.<bold>&#x000a0;</bold>Gallstones can cause both chronic pain and episodic discomfort. They also cause&#x000a0;acute disorders affecting the pancreatic, biliary, hepatic, and gastrointestinal tract. In the United States, over 6.3 million men and 14.2 million women between the ages of 20 and 74&#x000a0;have gallstones. Although most individuals with gallstones are asymptomatic, about 10%&#x000a0;may develop symptoms within&#x000a0;5 years and 20% within 20 years of diagnosis. The prevalence of gallstones increases with age. Over&#x000a0;25% of women older than 60 have gallstones.<xref ref-type="bibr" rid="article-22041.r1">[1]</xref></p>
        <p>Gallstones arise from metabolic, environmental, and genetic factors, and their composition depends on the etiology. Frequently&#x000a0;mobile, gallstones can migrate near the opening of the cystic duct, blocking the flow of bile and resulting in biliary colic. If the cystic duct is obstructed for more than a few hours, the gallbladder becomes inflamed and is prone to&#x000a0;infiltration from gut bacteria. If gallstones&#x000a0;travel into&#x000a0;a bile duct, they may cause biliary obstruction, leading to jaundice, abdominal pain, and cholangitis, and obstruction of the common bile duct can cause pancreatitis. Individuals&#x000a0;who have chronic gallstones may develop progressive fibrosis and loss of gallbladder motility.<xref ref-type="bibr" rid="article-22041.r1">[1]</xref></p>
        <p>Ultrasound is the preferred diagnostic modality for detecting gallstones, but gallstones may be visualized on computed tomography (CT), magnetic resonance imaging (MRI), and, depending on calcium content, even on x-rays. Treatment for gallstones depends on the clinical acuity and symptoms. The standard of care for patients experiencing recurrent biliary colic or acute cholecystitis is laparoscopic cholecystectomy. One million cholecystectomies are performed annually in the United States, at least half of which are secondary to biliary colic and chronic cholecystitis.<xref ref-type="bibr" rid="article-22041.r2">[2]</xref></p>
      </sec>
      <sec id="article-22041.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Primary bile acids are synthesized from cholesterol in the liver. Vitamin C promotes the conversion of cholesterol into bile acids through hydroxylation. These primary bile acids are converted into secondary bile acids in the intestine. Tertiary bile acids are further modified from secondary bile acids by intestinal flora or hepatocytes. Bile acids are soluble,&#x000a0;with a hydrophilic hydroxyl group, a glycine or taurine side chain, and a hydrophobic steroid ring.<xref ref-type="bibr" rid="article-22041.r3">[3]</xref> Gallstones are formed from bile products that precipitate out of solution, including cholesterol, breakdown products of red blood cells, and a mixture of calcium bilirubinate, phosphate, carbonate, palmitate, and cholesterol.&#x000a0;These products are suspended in a mucin glycoprotein matrix that acts as a nucleating factor for stone formation. Additional substances such as prostaglandins and arachidonyl lethicin promote stone crystallization.<xref ref-type="bibr" rid="article-22041.r4">[4]</xref></p>
        <p>Cholesterol is the main component of the most common type of gallstone. Black stones, composed of calcium bilirubinate, result from the breakdown of hemoglobin. In contrast, brown stones form in the setting of bacterial or parasitic infection and are composed of a combination of calcium substrates, including calcium bilirubinate, calcium phosphate or palmitate, cholesterol, and bile.<xref ref-type="bibr" rid="article-22041.r4">[4]</xref>&#x000a0;Cholesterol stones are prevalent in individuals with diabetes and other metabolic dysfunctions. In contrast, black stones occur in those with an inflammatory disease such as Crohn&#x000a0;disease or who undergo hemolysis, and brown-pigmented stones are observed in those with parasitic or bacterial infections and biliary strictures.<xref ref-type="bibr" rid="article-22041.r5">[5]</xref></p>
      </sec>
      <sec id="article-22041.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>In the United States, approximately 14 million women and 6 million men between the ages of&#x000a0;20 and 74 have gallstones. In 2023,&#x000a0;symptomatic gallstones accounted for 2 million ambulatory care visits, 1 million emergency department visits, 605,000 outpatient and 280,000 inpatient laparoscopic cholecystectomies, and 49,000 inpatient open cholecystectomies. The prevalence of gallstones increases with age, and the need for intervention secondary to gallstones has been growing amongst older adults, Hispanics, and women. Indigenous Americans also have a high prevalence of gallstones, cited as 70% by some sources.<xref ref-type="bibr" rid="article-22041.r6">[6]</xref>&#x000a0;Cholesterol gallstones are&#x000a0;increasing worldwide,&#x000a0;particularly in Westernized nations, and are believed to impact 20% of the European population.<xref ref-type="bibr" rid="article-22041.r7">[7]</xref></p>
        <p>Approximately 10% of individuals with gallstones develop symptoms within 5 years of diagnosis, 20% within 20 years, at a rate of 1% to 2% per year.<xref ref-type="bibr" rid="article-22041.r8">[8]</xref>&#x000a0;Of those with symptomatic gallstones, 1% to 2% experience complications, often due to common duct stones.<xref ref-type="bibr" rid="article-22041.r2">[2]</xref>&#x000a0;Common duct stones are discovered&#x000a0;during 5% to 15% of cholecystectomies, increasing with age.&#x000a0;The Swedish registry&#x000a0;cited a prevalence of common duct stones detected during 11% of interoperative cholangiograms in those with symptomatic gallstones.<xref ref-type="bibr" rid="article-22041.r9">[9]</xref></p>
        <p>There are multiple factors associated with an increased prevalence of gallstones. In Western nations, 75% of gallstones are cholesterol stones, associated with metabolic derangements such as dyslipidemia, diabetes, obesity, insulin resistance, and diets higher in saturated fats and sugar, and lower in fiber. Additional associations include lack of physical activity and conditions such as rapid weight loss or prolonged fasting that diminish gallbladder contractility and increase biliary secretion of cholesterol.<xref ref-type="bibr" rid="article-22041.r3">[3]</xref><xref ref-type="bibr" rid="article-22041.r10">[10]</xref><xref ref-type="bibr" rid="article-22041.r11">[11]</xref>&#x000a0;Genetic factors are believed to account for 25% to 30% of the risk of gallstone formation.<xref ref-type="bibr" rid="article-22041.r5">[5]</xref>&#x000a0;Estrogen levels have been shown to correlate with bile cholesterol&#x000a0;and a decrease in gallbladder contractility. Females of reproductive age&#x000a0;or taking estrogen-containing birth control medication have a two-fold increase in gallstone formation compared with males.<xref ref-type="bibr" rid="article-22041.r12">[12]</xref></p>
      </sec>
      <sec id="article-22041.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Gallstones occur when substances in bile exceed their solubility. As bile becomes supersaturated, small&#x000a0;crystals precipitate and become stuck in gallbladder mucus, resulting in&#x000a0;gallbladder sludge. Over time, these crystals coalesce and&#x000a0;form large stones. The stones are often mobile and can migrate into the bile ducts. Cholangitis and pancreatitis may result if the biliary system becomes obstructed.<xref ref-type="bibr" rid="article-22041.r12">[12]</xref>&#x000a0;Stones composed of calcium bilirubinate may also form primarily in the ducts, whereas stones formed in the gallbladder are predominantly cholesterol stones.<xref ref-type="bibr" rid="article-22041.r9">[9]</xref>&#x000a0;Gallstones are associated with&#x000a0;cirrhosis and form in the setting of biliary stasis from, for example, spinal cord injury and gastrectomy, and medications such as somatostatin and estrogen. Studies have found gallbladder innervation is diminished in those with gallstones.<xref ref-type="bibr" rid="article-22041.r10">[10]</xref></p>
        <p>Cholesterol stones result from increased bile cholesterol due to hepatic secretion and excess triglycerides. These factors promote the secretion of gallbladder mucin, contribute to a larger fasting gallbladder volume, reduce postprandial emptying, and impair intestinal motility. Excess biliary cholesterol can also cause gallbladder wall proliferation and inflammation.<xref ref-type="bibr" rid="article-22041.r3">[3]</xref><xref ref-type="bibr" rid="article-22041.r10">[10]</xref><xref ref-type="bibr" rid="article-22041.r13">[13]</xref>&#x000a0;Medications, phospholipid homeostasis, gut microbiome, diet, metabolic syndrome, hormonal and bacterial milieu, genetics, and even high altitude contribute to gallstone formation.<xref ref-type="bibr" rid="article-22041.r5">[5]</xref>&#x000a0;Fructose promotes gluconeogenesis and lipogenesis. Once glycogen accumulates in the liver, glycogen intermediates are&#x000a0;used for triglyceride synthesis, and hypertriglyceridemia can cause decreased gallbladder emptying and impaired contractility due to decreased sensitivity to cholecystokinin.<xref ref-type="bibr" rid="article-22041.r3">[3]</xref>&#x000a0;</p>
        <p>Cholesterol transporters can influence the amount of cholesterol in blood or bile.&#x000a0;Lecithin increases cholesterol concentration in bile carried in lecithin vesicles that fuse and form cholesterol hydrate crystals, which become the nucleus of a cholesterol stone. Bile composition influences the rate of cholesterol crystallization, and a hypoactive gallbladder allows more time for crystals to form.<xref ref-type="bibr" rid="article-22041.r13">[13]</xref>&#x000a0;Phospholipid lamella also transports excess cholesterol and plays a role in cholesterol crystalization in conjunction with prostaglandins and arachidonyl lecithin. Granulocytes and neutrophils are attracted to the cholesterol crystals, and neutrophils shed DNA onto the crystals, which attract similar crystals, thus forming larger stones.<xref ref-type="bibr" rid="article-22041.r5">[5]</xref><xref ref-type="bibr" rid="article-22041.r10">[10]</xref><xref ref-type="bibr" rid="article-22041.r13">[13]</xref></p>
        <p>Gallstones may form when there is an imbalance between the synthesis, dietary absorption, and recirculation of cholesterol.&#x000a0;When deactivated, genes that promote hepatic cholesterol secretion into bile may increase sensitivity to dietary cholesterol intake, contributing to hypercholesterolemia and coronary artery disease, and when overexpressed,&#x000a0;promote cholesterol secretion into the gallbladder, predisposing to stones.<xref ref-type="bibr" rid="article-22041.r13">[13]</xref>&#x000a0;Medications such as ezetimide and a state of insulin resistance inhibit cholesterol transport into the intestine and intestinal cholesterol absorption while promoting cholesterol synthesis, which is typically downregulated with increased dietary absorption.<xref ref-type="bibr" rid="article-22041.r10">[10]</xref><xref ref-type="bibr" rid="article-22041.r13">[13]</xref><xref ref-type="bibr" rid="article-22041.r10">[10]</xref></p>
        <p>Gallstones are promoted by and contribute to metabolic imbalances and disease processes. Insulin resistance stimulates cholesterol synthesis by upregulating 3-hydroxy-3-methylglutaryl coenzyme A reductase, upregulating cholesterol secretion, and reducing intestinal absorption of cholesterol independent of obesity. Gallstones reduce insulin sensitivity and increase hepatic triglycerides.&#x000a0;Obesity increases the size of hepatocytes, leading to a relative reduction in perfusion&#x000a0;and activation of a transcription factor that may promote gallstone formation.<xref ref-type="bibr" rid="article-22041.r10">[10]</xref>&#x000a0;</p>
        <p>Gallstones are associated with and may worsen cardiovascular disease. Studies show that individuals with gallstones have a higher risk of hypertension, diabetes mellitus, atrial fibrillation, hyperlipidemia, coronary artery disease, and cerebrovascular disease.<xref ref-type="bibr" rid="article-22041.r13">[13]</xref>&#x000a0;Autonomic neuropathy in individuals with diabetes&#x000a0;is correlated with a greater number of gallstones.<xref ref-type="bibr" rid="article-22041.r10">[10]</xref>&#x000a0;Diminished gallbladder contractions may, in part, be due to a reduced amount of cholecystokinin released by the duodenum, leading to more gallstone formation. Lower fiber intake decreases colonic motility and increases the production of stone-forming secondary bile acids.<xref ref-type="bibr" rid="article-22041.r13">[13]</xref></p>
        <p>Bile becomes more saturated with cholesterol during weight loss, but this has not been demonstrated following bariatric surgery.&#x000a0;Following a Roux-en-Y gastric bypass, gallbladder emptying slows&#x000a0;down, and its ejection fraction is reduced.&#x000a0;Haal et al&#x000a0;hypothesize that gallstone formation following bariatric surgery is on this basis, allowing time for gallstone crystallization, with an altered triglyceride composition that increases biliary cholesterol.<xref ref-type="bibr" rid="article-22041.r14">[14]</xref>&#x000a0; Individuals with&#x000a0;decreased gallbladder emptying who have not undergone bariatric surgery, such as those on a low-calorie diet, have a greater concentration of bile acid and phospholipids but have cholesterol levels&#x000a0;comparable to those with&#x000a0;normal&#x000a0;gallbladder emptying.<xref ref-type="bibr" rid="article-22041.r14">[14]</xref>&#x000a0;</p>
        <p>Hormones can impact the formation of gallstones. Hormones&#x000a0;such as vasoactive intestinal peptide and human fibroblast growth factor&#x000a0;impact the gallbladder emptying and refilling phase in the postprandial period, released&#x000a0;in response to&#x000a0;increased acid in the duodenum.&#x000a0;These hormones are activated when bile acids reach the terminal ileum, resulting in gallbladder relaxation and filling.&#x000a0;Estrogen upregulates cholesterol synthesis and decreases bile acid synthesis by upregulating estrogen receptor alpha and a G-protein&#x02013;coupled receptor.<xref ref-type="bibr" rid="article-22041.r10">[10]</xref>&#x000a0;In the liver, estrogen passively diffuses into cells and promotes cholesterol secretion into bile, increasing saturation.<xref ref-type="bibr" rid="article-22041.r13">[13]</xref></p>
        <p>Bacterial infiltration of the gallbladder is promoted by bile stasis and impaired gallbladder motility. Organisms may enter the biliary system through the sphincter of Oddi or may invade the liver and bile through a hematogenous route, where they serve as stone nucleators.&#x000a0;Mucus glycoprotein and phospholipid lamella initiate the&#x000a0;crystallization of cholesterol stones,&#x000a0;acting in conjunction with prostaglandins and arachidonyl lecithin in a milieu of cholesterol supersaturation, gallbladder hypomotility, and infection.<xref ref-type="bibr" rid="article-22041.r5">[5]</xref><xref ref-type="bibr" rid="article-22041.r13">[13]</xref></p>
        <p>Bacteria that produce biofilms are associated with stone formation. A study comparing gut bacteria in individuals with and without gallstones found different subsets of bacteria dominant in each group.<xref ref-type="bibr" rid="article-22041.r15">[15]</xref><xref ref-type="bibr" rid="article-22041.r16">[16]</xref>&#x000a0;Gram-positive anaerobes are linked to greater amounts of the stone-forming secondary bile acid deoxycholate.<xref ref-type="bibr" rid="article-22041.r10">[10]</xref>&#x000a0;An analysis of genomes of bacteria within cholesterol versus pigmented stones found gram-positive bacteria within cholesterol stones but not pigmented stones.&#x000a0;Microflora impact cholecystokinin secretion and immunomodulate mucin genes, which contribute to the nucleation of cholesterol gallstones.<xref ref-type="bibr" rid="article-22041.r13">[13]</xref></p>
        <p>When&#x000a0;cholesterol gallstones&#x000a0;are colonized with microorganisms, the resulting leucocyte infiltration into the gallbladder mucosa in the presence of bilirubin leads to the formation of mixed stones.&#x000a0;There are fewer&#x000a0;beneficial bacteria, less bacterial diversity, and more pathogenic bacteria in&#x000a0;individuals with gallstones. Gut bacteria impact the production of bile acids.<xref ref-type="bibr" rid="article-22041.r13">[13]</xref>&#x000a0;Bateria-Sharma et al isolated bacteria from gallstones and introduced them into synthetic bile-like environments containing varying amounts of cholesterol and calcium carbonate. After 20 days of incubation, they found that the slime activity of bacteria correlated with gallstone formation and other bacterial properties hastened the nucleation of gallstones.<xref ref-type="bibr" rid="article-22041.r17">[17]</xref>&#x000a0;</p>
        <p>The gut microbiome is altered by toxins such as pesticides&#x000a0;and&#x000a0;heavy metals, which may increase the risk of gallstones.<xref ref-type="bibr" rid="article-22041.r10">[10]</xref>&#x000a0;Polyfluoroalkyl substances (PFAS) are synthetic compounds that are commonly used&#x000a0;in industry and consumables. They are internalized through inhalation and ingestion and accumulate in plasma, liver, kidneys, and bile. PFAS are increasingly found in humans and animals, can incorporate into bile moving through the enterohepatic circulation, and can also directly disrupt enterohepatic circulation. PFAS also interferes with lipid metabolism, hepatocyte function, and the regulation of androgens and estrogen.<xref ref-type="bibr" rid="article-22041.r18">[18]</xref></p>
        <p>Higher altitude may increase the risk of gallstone formation due to induced hepatic hypoxia, postulated from the upregulation of trimethylamine-<italic toggle="yes">N</italic>-oxide (TMAO), a monooxygenase that leads to cholesterol stone formation. Hypoxia promotes the expression of hepatic <italic toggle="yes">hypoxia-inducible factor 1 alpha</italic>, which upregulates TMAO,&#x000a0;leading to the increased production of cholesterol gallstones.<xref ref-type="bibr" rid="article-22041.r19">[19]</xref></p>
        <p>Certain genes are associated with an increased susceptibility to gallstones, including those involved with hepatic cholesterol secretion, apolipoprotein genes, mucin genes, and fibroblast growth receptor genes. Specifically, a polymorphism of the mucin-like protocadherin gene, <italic toggle="yes">rs3758650</italic>,&#x000a0;is linked to a higher risk of developing symptomatic gallstones.<xref ref-type="bibr" rid="article-22041.r10">[10]</xref>&#x000a0;The influence of environmental factors such as insulin resistance on genes involving cholesterol transport and metabolism can&#x000a0;result in epigenetic changes, resulting in increased biliary cholesterol secretion. Gene knockouts result in&#x000a0;reduced biliary cholesterol secretion and increased&#x000a0;hydrophilic bile acids.<xref ref-type="bibr" rid="article-22041.r10">[10]</xref></p>
      </sec>
      <sec id="article-22041.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Gallstones may be asymptomatic and discovered incidentally or cause symptoms ranging from intermittent colicky pain to constant discomfort or even sepsis. A classic description of biliary colic includes crampy post-prandial right upper quadrant or epigastric pain radiating to the back or scapula, particularly evident following a&#x000a0;high-fat meal, often accompanied by nausea and vomiting. If the gallbladder becomes acutely inflamed with bacterial infiltration, the pain is typically constant and progressive. Classic gallbladder pain is described as subcostal right upper quadrant pain elicited by palpation during inspiration. Pain may also present in the substernal area or left upper quadrant.<xref ref-type="bibr" rid="article-22041.r9">[9]</xref><xref ref-type="bibr" rid="article-22041.r20">[20]</xref></p>
        <p>Acute cholecystitis often involves more severe, at times unrelenting pain, and a mass may be palpated in the right upper quadrant, representing an edematous and thickened gallbladder. Jaundice, a sign&#x000a0;of biliary obstruction, may be evident. Ascending cholangitis, involving bacterial infiltration of the&#x000a0;biliary system, presents with right upper quadrant pain, fever, and jaundice (Charcot triad). If left untreated,&#x000a0;progressive decline&#x000a0;includes neurologic changes and hypotension (Reynold's pentad). Gallstone obstruction in the proximity of the pancreatic duct may cause acute pancreatitis with symptoms of mid-epigastric pain and intractable vomiting.<xref ref-type="bibr" rid="article-22041.r20">[20]</xref></p>
      </sec>
      <sec id="article-22041.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Ultrasound has a 90% specificity for gallstones and can detect stones as small as 2 mm, along with sludge and gallbladder polyps. Ultrasound findings&#x000a0;of acute cholecystitis include gallbladder wall thickening greater than 3 mm, pericholecystic fluid, and a painful response to pressure from the ultrasound probe (Murphy sign). Gallstones can also often be identified on&#x000a0;CT scans and MRI, but these modalities are not as sensitive for diagnosing acute cholecystitis. Approximately 10% of gallstones may be visualized on x-rays due to their calcium content.<xref ref-type="bibr" rid="article-22041.r21">[21]</xref></p>
        <p>Dilation of the common bile duct observed on imaging may indicate the presence of a common duct stone.&#x000a0;Endoscopic retrograde cholangiopancreatography (ERCP) and magnetic retrograde cholangiopancreatography (MRCP) have high sensitivity and specificity for identifying common duct stones. MRCP is noninvasive but is limited by cost and availability, whereas ERCP is the most common modality for treatment if a common duct stone is identified on MRCP.<xref ref-type="bibr" rid="article-22041.r9">[9]</xref>&#x000a0;The common duct may be evaluated during a laparoscopic cholecystectomy using fluoroscopy with an intraoperative cholangiogram or&#x000a0;through a percutaneous transhepatic cholangiogram if an ERCP&#x000a0;is&#x000a0;not an option. Some clinicians perform routine intraoperative cholangiograms, whereas others perform them selectively.<xref ref-type="bibr" rid="article-22041.r21">[21]</xref></p>
        <p>The Japanese Society of Gastroenterology provides evidence-based guidelines, revised in 2021,&#x000a0;for an evaluation protocol of suspected gallstones. According to these guidelines, once gallstones are identified on imaging, patients are divided into those with and without cholecystitis,&#x000a0;using criteria including pain, elevated white blood cell (WBC) count, c-reaction protein, pericholecystic fluid, and thickening of the gallbladder wall.<xref ref-type="bibr" rid="article-22041.r8">[8]</xref></p>
        <p>Laboratory tests that help evaluate the clinical impact of gallstones, such as in biliary obstruction and calculous cholecystitis, include liver function tests, bilirubin, alkaline phosphatase, and WBC count. Liver aminotransferase and alkaline phosphatase typically show mild-to-moderate elevation with acute cholecystitis and during and following biliary obstruction, while conjugated (direct) bilirubin levels are elevated.<xref ref-type="bibr" rid="article-22041.r22">[22]</xref></p>
      </sec>
      <sec id="article-22041.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Laparoscopic cholecystectomy is the standard of care for symptomatic gallstones. Open cholecystectomy is reserved for&#x000a0;cases where the laparoscopic approach is not feasible or safe. In cases of acute cholecystitis in&#x000a0;unstable patients or patients who are poor surgical candidates, a cholecystostomy tube can be placed by interventional radiology as either a temporizing or palliative measure.<xref ref-type="bibr" rid="article-22041.r9">[9]</xref></p>
        <p>Common bile duct stones can be removed with a preoperative, postoperative, or intraoperative ERCP, or intraoperatively with a laparoscopic or open common bile duct exploration. During a common bile duct exploration, the common duct is accessed&#x000a0;through&#x000a0;the cystic duct&#x000a0;and visualized fluoroscopically or accessed directly through a choledochotomy and visualized using a choledochoscope. The choledochoscope requires a second monitor, and fluoroscopy utilizes radiation, but both are effective approaches.<xref ref-type="bibr" rid="article-22041.r23">[23]</xref>&#x000a0;A common duct incision risks subsequent duct stenosis and requires&#x000a0;skilled closure. The common bile duct can be anastomosed to the bowel, in a side-to-side anastomosis or a Roux-en-Y choledochojejunostomy to avoid stenosis. Alternatively, the duct&#x000a0;opening can be controlled with a t-tube. However, intubation of the duct may introduce bacteria into the biliary system and the tube may become displaced, causing bile peritonitis.<xref ref-type="bibr" rid="article-22041.r9">[9]</xref></p>
        <p>A strategy for intraoperative ERCP involves a combination of laparoscopic and endoscopic approaches. In this approach, a guidewire is introduced into the cystic duct, passes through the Ampulla of Vater into the duodenum, and then grasped by a snare through the endoscope. A sphincterotome is passed over the guidewire to perform sphincterotomy and remove stones.<xref ref-type="bibr" rid="article-22041.r9">[9]</xref>&#x000a0;This method provides for a shorter hospital stay, reduced cost, and a lesser amount of anesthesia, but requires greater expertise and coordination of personnel.<xref ref-type="bibr" rid="article-22041.r9">[9]</xref></p>
        <p>Ascending cholangitis must be urgently addressed by removing the obstruction, using endoscopic instrumentation or percutaneous transhepatic intervention&#x000a0;or surgery, and administering early antibiotics. Cholecystectomy should be performed after recovery from acute illness.<xref ref-type="bibr" rid="article-22041.r7">[7]</xref><xref ref-type="bibr" rid="article-22041.r24">[24]</xref>&#x000a0;</p>
        <p>Pharmacologic or mechanical treatment for gallstones is not commonly used due to low efficacy.<xref ref-type="bibr" rid="article-22041.r2">[2]</xref>&#x000a0;Lithotripsy does not&#x000a0;impede stone formation and the procedure requires trained personnel. However, there is a limited role for lithotripsy as part of a multi-modal approach for difficult stones. Mechanical lithotripsy can be a secondary maneuver following failed sphincterotomy for common duct stones, and electrohydraulic lithotripsy or laser lithotripsy can be used in an attempt to break up stones under fluoroscopy. Laser therapy, however, is expensive and limited by excessive heat.&#x000a0;Extracorporeal shock-wave lithotripsy may be attempted to help treat challenging common duct stones, but efficacy is relatively low.<xref ref-type="bibr" rid="article-22041.r7">[7]</xref> During shock-wave lithotripsy, most operators use compressible water-filled bags placed externally on the body, but this is painful and requires pain intraprocedural pain management. Extracorporeal shock-wave treatment is contraindicated in the setting of portal thrombus and umbilical varices and can cause arrhythmias, haemobilia, cholangitis, pancreatitis, ileus, and biliary colic.<xref ref-type="bibr" rid="article-22041.r9">[9]</xref></p>
        <p>Ursodeoxycholic acid, or ursodiol, is a bile acid used to dissolve bile stones and treat liver pathology such as biliary cirrhosis. Although it can be administered daily with the goal of gallstone dissolution, the dissolution rate is &#x0003c;50%, and the underlying etiology is not addressed. Pharmacologic therapy intended to mitigate the formation of gallstones includes statins such as&#x000a0;ezetimibe. Statins&#x000a0;block&#x000a0;hepatic cholesterol synthesis through the inhibition of the&#x000a0;hydroxymethylglutaryl-coenzyme A reductase enzyme and the activation of peroxisome proliferator-activated receptor gamma.<xref ref-type="bibr" rid="article-22041.r5">[5]</xref>&#x000a0;Alternative therapies to treat gallstones include defatted walnut powder extract, which contains juglandis attributed to phenolic acids, and a medley of Chinese herbs.<xref ref-type="bibr" rid="article-22041.r5">[5]</xref></p>
      </sec>
      <sec id="article-22041.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The signs and symptoms associated with gallstones may also be observed in the following conditions:</p>
        <list list-type="bullet">
          <list-item>
            <p>Appendicitis</p>
          </list-item>
          <list-item>
            <p>Renal calculi</p>
          </list-item>
          <list-item>
            <p>Cholangiocarcinoma</p>
          </list-item>
          <list-item>
            <p>Pancreatitis</p>
          </list-item>
          <list-item>
            <p>Peptic ulcer disease</p>
          </list-item>
          <list-item>
            <p>Gastroesophageal reflux disease</p>
          </list-item>
          <list-item>
            <p>Myocardial infarction</p>
          </list-item>
          <list-item>
            <p>Aortic dissection</p>
          </list-item>
          <list-item>
            <p>Pneumonia</p>
          </list-item>
          <list-item>
            <p>Esophageal spasm</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-22041.s10" sec-type="Pertinent Studies and Ongoing Trials">
        <title>Pertinent Studies and Ongoing Trials</title>
        <p>Shenoy et al reviewed the literature on treating&#x000a0;symptomatic cholelithiasis in adults from 2000 to 2020, including operative and non-operative approaches. Variables measured included length of stay and hospital readmission.&#x000a0;Interventions compared included&#x000a0;cholecystectomy versus observation, cholecystectomy versus lithotripsy, elective versus urgent cholecystectomy, pharmacologic intervention to treat gallstones, and pain management with observation.<xref ref-type="bibr" rid="article-22041.r2">[2]</xref></p>
        <p>The findings indicate that individuals who underwent surgery experienced better pain control compared to those who received lithotripsy for gallstones. In addition, for patients with uncontrolled pain, surgery was more effective compared to merely observing their condition without intervention. When comparing elective to urgent surgery, it was noted that 25% of individuals&#x000a0;who underwent elective surgery required additional treatment before their surgery date.&#x000a0;No significant differences were found in individuals treated with chenodeoxycholic or ursodeoxycholic acid versus placebo in pain or stone dissolution.&#x000a0;A study compared acupuncture versus observation for gallstone clearance or dissolution and found no difference. In the pain management category, loxiglumide, a cholecystokinin-1 receptor blocker, was superior to hyoscine-<italic toggle="yes">N</italic>-butyl bromide, an anticholinergic.<xref ref-type="bibr" rid="article-22041.r2">[2]</xref>&#x000a0;</p>
        <p>When recommending treatment, the authors recommended stratification of patients by symptoms, including time to symptom onset and severity of recurrent symptoms.&#x000a0;They note that early intervention in those with symptomatic gallstones eliminates clinical decline and complications experienced during the waiting period and that waiting results in greater costs and increased morbidity. Patient stratification helps calculate the risk of complications from elective rather than urgent intervention.<xref ref-type="bibr" rid="article-22041.r2">[2]</xref></p>
      </sec>
      <sec id="article-22041.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Although&#x000a0;gallstones&#x000a0;are prognostically favorable, in the United States, they&#x000a0;are&#x000a0;associated with increased mortality from cardiovascular disease and cancer.<xref ref-type="bibr" rid="article-22041.r25">[25]</xref> Less than 50% of individuals&#x000a0;with gallstones develop symptoms.&#x000a0;Individuals who undergo cholecystectomy may experience mild bloating and other gastrointestinal symptoms, such as post-prandial diarrhea, exacerbated by fattier foods, but generally enjoy longevity and quality of life comparable to those without gallstones. The mortality rate following laparoscopic cholecystectomy is less than 0.5% but greater for emergency cases. A recent study based in India found a 30-day morbidity for cholecystectomy of 11% and mortality of 0.2%. Factors associated with increased morbidity included greater body mass index, history of previous abdominal surgery, intraabdominal adhesions, conversion to an open procedure, and gangrenous gallbladder. The study's conversion from laparoscopic to open was 1.3%, and the bile duct injury rate was 0.3%.<xref ref-type="bibr" rid="article-22041.r26">[26]</xref></p>
        <p>Ahmad H M Nassar et al identified individuals&#x000a0;with body mass index (BMI) &#x0003e;35 amongst 4699 laparoscopic cholecystectomies performed over 19 years&#x000a0;and found&#x000a0;no significant difference in operative times, morbidity, operative difficulty, readmission, or mortality compared with a leaner control group.<xref ref-type="bibr" rid="article-22041.r27">[27]</xref>&#x000a0;Fagenson et al found a direct correlation between frailty as measured by the Modified Frailty Index and postoperative morbidity and mortality following laparoscopic cholecystectomy for acute cholecystitis.<xref ref-type="bibr" rid="article-22041.r28">[28]</xref>&#x000a0;Fugazzola et al developed a preoperative risk score for individuals&#x000a0;undergoing cholecystectomy for acute calculous cholecystitis&#x000a0;through&#x000a0;a multicenter observational study&#x000a0;from September 2021&#x000a0;to September 2022, including 1253 individuals&#x000a0;in 79 centers. The findings revealed a 30-day morbidity of 6.6 % and a 30-day mortality of 1%.<xref ref-type="bibr" rid="article-22041.r29">[29]</xref></p>
      </sec>
      <sec id="article-22041.s12" sec-type="Complications">
        <title>Complications</title>
        <p>Gallstones may&#x000a0;cause gallbladder inflammation, leading to acute or chronic cholecystitis,&#x000a0;empyema, gangrenous cholecystitis, and emphysematous cholecystitis. Stones stuck within the common bile duct&#x000a0;can cause obstruction, jaundice, proximal dilation of the biliary tree, pancreatitis, and cholangitis.<xref ref-type="bibr" rid="article-22041.r30">[30]</xref><xref ref-type="bibr" rid="article-22041.r31">[31]</xref><xref ref-type="bibr" rid="article-22041.r32">[32]</xref>&#x000a0;Gallstones may also externally compress&#x000a0;a bile duct, such as the common bile duct or hepatic duct, from within the cystic duct or gallbladder neck, a condition known as Mirizzi syndrome. Gallstones may become impacted within the gallbladder and&#x000a0;erode the wall, resulting in a cholecystoenteric fistula between the gallbladder and the bowel, most commonly the duodenum, also called Bouveret syndrome. A gallstone can cause an ileus in the small bowel, occurring in 0.3% to 0.5% of individuals with gallstones.<xref ref-type="bibr" rid="article-22041.r8">[8]</xref><xref ref-type="bibr" rid="article-22041.r9">[9]</xref><xref ref-type="bibr" rid="article-22041.r33">[33]</xref></p>
        <p>There are procedural complications from ERCP, including injury to bile ducts and duodenum, haemobilia, and pancreatitis, and there are rare case reports of pulmonary bile embolism after&#x000a0;ERCP for gallstone pancreatitis.<xref ref-type="bibr" rid="article-22041.r9">[9]</xref>&#x000a0;Complications&#x000a0;encountered during&#x000a0;or after cholecystectomy include injury to a bile duct or bowel, retained stones in the common bile duct, incisional hernia, and chronic right upper quadrant pain.<xref ref-type="bibr" rid="article-22041.r34">[34]</xref></p>
      </sec>
      <sec id="article-22041.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>A&#x000a0;higher intake of monounsaturated fats, fiber, olive oil, omega-3 fatty acids, and vegetable protein is protective against gallstones.&#x000a0;Specifically, polyunsaturated fatty acids may assist with gallbladder emptying, and vegetable protein, vitamin C-rich fruits and vegetables, and coffee may increase gallbladder motility. In addition, exercise may help mitigate gallstone formation.<xref ref-type="bibr" rid="article-22041.r7">[7]</xref> A&#x000a0;diet higher in refined sugars, fructose, and fast food&#x000a0;with insufficient fiber and vitamin C, and a setting of increased insulin requirements increases the risk of gallstones.<xref ref-type="bibr" rid="article-22041.r11">[11]</xref></p>
      </sec>
      <sec id="article-22041.s14" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Asymptomatic choledocholithiasis can be managed conservatively, depending on symptoms and complications.<xref ref-type="bibr" rid="article-22041.r35">[35]</xref>&#x000a0;Gallstones in pregnancy are associated with worse maternal and neonatal outcomes, including preterm birth. Cholecystectomy can be performed safely during the early and mid stages of pregnancy.<xref ref-type="bibr" rid="article-22041.r10">[10]</xref></p>
      </sec>
      <sec id="article-22041.s15" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Gallstones may be asymptomatic, present with intermittent symptoms of varying severity, or&#x000a0;lead to&#x000a0;more severe illness.Whether gallstones identified on imaging pose any clinical issues may not be clear.&#x000a0;If symptomatic, planning for intervention requires discussion between the interprofessional team and patient, including input from the primary care team, surgeon, radiologist, and possibly a gastroenterologist/ERCP endoscopist. Early consultation with a general surgeon is often beneficial. Should gallstones cause recurrent or persistent symptoms, early intervention reduces the need for emergency department care and the risk of complications.<xref ref-type="bibr" rid="article-22041.r36">[36]</xref></p>
        <p>Not all gallstones require surgery. Lifestyle modification, including a&#x000a0;low-fat diet, regular exercise, and abstaining from prolonged fasting, may help minimize symptoms. Postoperatively,&#x000a0;patients require&#x000a0;education regarding diet and activity and may require follow-up for any digestive difficulties. Close communication between team members is vital to lower the morbidity of gallstones.<xref ref-type="bibr" rid="article-22041.r36">[36]</xref><xref ref-type="bibr" rid="article-22041.r37">[37]</xref><xref ref-type="bibr" rid="article-22041.r38">[38]</xref></p>
      </sec>
      <sec id="article-22041.s16">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=22041&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=22041">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/health/gallstones-cholelithiasis/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=22041">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/22041/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=22041">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-22041.s17">
        <fig id="article-22041.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Gallstone on Point-of-Care Ultrasound. Contributed by the Emory Emergency Medicine Ultrasound Section</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="GB__stone__with__shadowing.0001" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-22041.s18">
        <fig id="article-22041.image.f2" position="float" orientation="portrait">
          <caption>
            <p>CT Acute Cholecystitis Wall Thickening Pericholecystic Fluid Gallstone Contributed by Scott Dulebohn, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="acute__chole__ct_1" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-22041.s19">
        <fig id="article-22041.image.f3" position="float" orientation="portrait">
          <caption>
            <p>Gallstones in a female Image courtesy S Bhimji</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="galldtones" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-22041.s20">
        <fig id="article-22041.image.f4" position="float" orientation="portrait">
          <caption>
            <p>Multiple Biliary Hamartoma. Ultrasound of a 37-year-old female diagnosed with gallstones with acute cholecystitis. The incidental findings: (A)&#x000a0;US image shows multiple hypoechoic lesions, some of them with comet-tail artifacts, raising the possibility of multiple biliary hamartoma.&#x000a0;(B) T2-weighted MRI shows numerous cystic lesions with a signal similar to CSF.&#x000a0;(C)&#x000a0;Post-contrast T2 weighted MRI shows some of these lesions with enhancing mural nodule, highly specific for biliary hamartoma.&#x000a0;(D)&#x000a0;MRCP 3D projection image has more lesions and demonstrates no communication with normal caliber biliary duct. Contributed by A Borhani, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Figure__1" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-22041.s21">
        <fig id="article-22041.image.f5" position="float" orientation="portrait">
          <caption>
            <p>Gallbladder Gallstones (Calculi), Common 
bile duct, Pancreas, Intestine, Gallbladder, Gallstones, Liver Illustration by Emma Gregory</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Gallstones-01" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-22041.s22">
        <title>References</title>
        <ref id="article-22041.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tsai</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Chan</surname>
                <given-names>HH</given-names>
              </name>
              <name>
                <surname>Lai</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Shih</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Kao</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Sun</surname>
                <given-names>WC</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Tsai</surname>
                <given-names>WL</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Yu</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>WC</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Tsay</surname>
                <given-names>FW</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Cheng</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Hsu</surname>
                <given-names>PI</given-names>
              </name>
            </person-group>
            <article-title>Gallbladder function predicts subsequent biliary complications in patients with common bile duct stones after endoscopic treatment?</article-title>
            <source>BMC Gastroenterol</source>
            <year>2018</year>
            <month>Feb</month>
            <day>27</day>
            <volume>18</volume>
            <issue>1</issue>
            <fpage>32</fpage>
            <pub-id pub-id-type="pmid">29486713</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22041.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shenoy</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kirkland</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Hadaya</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Tranfield</surname>
                <given-names>MW</given-names>
              </name>
              <name>
                <surname>DeVirgilio</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Russell</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Maggard-Gibbons</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Management of symptomatic cholelithiasis: a systematic review.</article-title>
            <source>Syst Rev</source>
            <year>2022</year>
            <month>Dec</month>
            <day>12</day>
            <volume>11</volume>
            <issue>1</issue>
            <fpage>267</fpage>
            <pub-id pub-id-type="pmid">36510302</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22041.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Di Ciaula</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Garruti</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Fr&#x000fc;hbeck</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>De Angelis</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>de Bari</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>DQ</given-names>
              </name>
              <name>
                <surname>Lammert</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Portincasa</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>The Role of Diet in the Pathogenesis of Cholesterol Gallstones.</article-title>
            <source>Curr Med Chem</source>
            <year>2019</year>
            <volume>26</volume>
            <issue>19</issue>
            <fpage>3620</fpage>
            <page-range>3620-3638</page-range>
            <pub-id pub-id-type="pmid">28554328</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22041.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rebholz</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Krawczyk</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lammert</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Genetics of gallstone disease.</article-title>
            <source>Eur J Clin Invest</source>
            <year>2018</year>
            <month>Jul</month>
            <volume>48</volume>
            <issue>7</issue>
            <fpage>e12935</fpage>
            <pub-id pub-id-type="pmid">29635711</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22041.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>E</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Srikanth</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Shreyas</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Desai</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mehdi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gangadharappa</surname>
                <given-names>HV</given-names>
              </name>
              <name>
                <surname>Suman</surname>
              </name>
              <name>
                <surname>Krishna</surname>
                <given-names>KL</given-names>
              </name>
            </person-group>
            <article-title>Recent advances, novel targets and treatments for cholelithiasis; a narrative review.</article-title>
            <source>Eur J Pharmacol</source>
            <year>2021</year>
            <month>Oct</month>
            <day>05</day>
            <volume>908</volume>
            <fpage>174376</fpage>
            <pub-id pub-id-type="pmid">34303667</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22041.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Unalp-Arida</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ruhl</surname>
                <given-names>CE</given-names>
              </name>
            </person-group>
            <article-title>Burden of gallstone disease in the United States population: Prepandemic rates and trends.</article-title>
            <source>World J Gastrointest Surg</source>
            <year>2024</year>
            <month>Apr</month>
            <day>27</day>
            <volume>16</volume>
            <issue>4</issue>
            <fpage>1130</fpage>
            <page-range>1130-1148</page-range>
            <pub-id pub-id-type="pmid">38690054</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22041.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gutt</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Schl&#x000e4;fer</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lammert</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>The Treatment of Gallstone Disease.</article-title>
            <source>Dtsch Arztebl Int</source>
            <year>2020</year>
            <month>Feb</month>
            <day>28</day>
            <volume>117</volume>
            <issue>9</issue>
            <fpage>148</fpage>
            <page-range>148-158</page-range>
            <pub-id pub-id-type="pmid">32234195</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22041.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fujita</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Yasuda</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Endo</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Isayama</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Iwashita</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ueki</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Uemura</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Umezawa</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Katanuma</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Katayose</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Suzuki</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Shoda</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Tsuyuguchi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Wakai</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Inui</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Unno</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Takeyama</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Itoi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Koike</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Mochida</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Evidence-based clinical practice guidelines for cholelithiasis 2021.</article-title>
            <source>J Gastroenterol</source>
            <year>2023</year>
            <month>Sep</month>
            <volume>58</volume>
            <issue>9</issue>
            <fpage>801</fpage>
            <page-range>801-833</page-range>
            <pub-id pub-id-type="pmid">37452855</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22041.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cianci</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Restini</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Management of cholelithiasis with choledocholithiasis: Endoscopic and surgical approaches.</article-title>
            <source>World J Gastroenterol</source>
            <year>2021</year>
            <month>Jul</month>
            <day>28</day>
            <volume>27</volume>
            <issue>28</issue>
            <fpage>4536</fpage>
            <page-range>4536-4554</page-range>
            <pub-id pub-id-type="pmid">34366622</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22041.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Di Ciaula</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>DQ</given-names>
              </name>
              <name>
                <surname>Portincasa</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>An update on the pathogenesis of cholesterol gallstone disease.</article-title>
            <source>Curr Opin Gastroenterol</source>
            <year>2018</year>
            <month>Mar</month>
            <volume>34</volume>
            <issue>2</issue>
            <fpage>71</fpage>
            <page-range>71-80</page-range>
            <pub-id pub-id-type="pmid">29283909</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22041.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kotrotsios</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tasis</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Angelis</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Apostolopoulos</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Vlasis</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Papadopoulos</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Filippou</surname>
                <given-names>DK</given-names>
              </name>
            </person-group>
            <article-title>Dietary Intake and Cholelithiasis: A Review.</article-title>
            <source>J Long Term Eff Med Implants</source>
            <year>2019</year>
            <volume>29</volume>
            <issue>4</issue>
            <fpage>317</fpage>
            <page-range>317-326</page-range>
            <pub-id pub-id-type="pmid">32749137</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22041.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shabanzadeh</surname>
                <given-names>DM</given-names>
              </name>
            </person-group>
            <article-title>New determinants for gallstone disease?&#x02029;.</article-title>
            <source>Dan Med J</source>
            <year>2018</year>
            <month>Feb</month>
            <volume>65</volume>
            <issue>2</issue>
            <pub-id pub-id-type="pmid">29393043</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22041.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sun</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Warren</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Yip</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ji</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Hao</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Han</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Ding</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Factors Influencing Gallstone Formation: A Review of the Literature.</article-title>
            <source>Biomolecules</source>
            <year>2022</year>
            <month>Apr</month>
            <day>06</day>
            <volume>12</volume>
            <issue>4</issue>
            <pub-id pub-id-type="pmid">35454138</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22041.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Haal</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Guman</surname>
                <given-names>MSS</given-names>
              </name>
              <name>
                <surname>Acherman</surname>
                <given-names>YIZ</given-names>
              </name>
              <name>
                <surname>Jansen</surname>
                <given-names>JPG</given-names>
              </name>
              <name>
                <surname>van Weeghel</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>van Lenthe</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Wever</surname>
                <given-names>EJM</given-names>
              </name>
              <name>
                <surname>Gerdes</surname>
                <given-names>VEA</given-names>
              </name>
              <name>
                <surname>Voermans</surname>
                <given-names>RP</given-names>
              </name>
              <name>
                <surname>Groen</surname>
                <given-names>AK</given-names>
              </name>
            </person-group>
            <article-title>Gallstone Formation Follows a Different Trajectory in Bariatric Patients Compared to Nonbariatric Patients.</article-title>
            <source>Metabolites</source>
            <year>2021</year>
            <month>Oct</month>
            <day>05</day>
            <volume>11</volume>
            <issue>10</issue>
            <pub-id pub-id-type="pmid">34677397</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22041.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Boyang</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Yanjun</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Jing</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Chenxin</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Ying</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Shuwen</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Qiang</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Investigating the influence of the gut microbiome on cholelithiasis: unveiling insights through sequencing and predictive modeling.</article-title>
            <source>J Appl Microbiol</source>
            <year>2024</year>
            <month>May</month>
            <day>01</day>
            <volume>135</volume>
            <issue>5</issue>
            <pub-id pub-id-type="pmid">38614959</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22041.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hu</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Shao</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Weng</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Lu</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Jiao</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Sun</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Jiang</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Gu</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Gut microbiota promotes cholesterol gallstone formation by modulating bile acid composition and biliary cholesterol secretion.</article-title>
            <source>Nat Commun</source>
            <year>2022</year>
            <month>Jan</month>
            <day>11</day>
            <volume>13</volume>
            <issue>1</issue>
            <fpage>252</fpage>
            <pub-id pub-id-type="pmid">35017486</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22041.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sharma</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sachan</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>SR</given-names>
              </name>
            </person-group>
            <article-title>In vitro analysis of gallstone formation in the presence of bacteria.</article-title>
            <source>Indian J Gastroenterol</source>
            <year>2020</year>
            <month>Oct</month>
            <volume>39</volume>
            <issue>5</issue>
            <fpage>473</fpage>
            <page-range>473-480</page-range>
            <pub-id pub-id-type="pmid">33201443</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22041.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Sun</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Xie</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Zou</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Ren</surname>
                <given-names>X</given-names>
              </name>
            </person-group>
            <article-title>Individual and joint associations of per- and polyfluoroalkyl substances (PFAS) with gallstone disease in adults: A cross-sectional study.</article-title>
            <source>Chemosphere</source>
            <year>2024</year>
            <month>Jun</month>
            <volume>358</volume>
            <fpage>142168</fpage>
            <pub-id pub-id-type="pmid">38685323</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22041.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Luo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Tian</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Rigzin</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Sonam</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Shang</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Tai</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Sang</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Hif-1&#x003b1; expression targets the TMA/Fmo3/TMAO axis to participate in gallbladder cholesterol stone formation in individuals living in plateau regions.</article-title>
            <source>Biochim Biophys Acta Mol Basis Dis</source>
            <year>2024</year>
            <month>Jun</month>
            <volume>1870</volume>
            <issue>5</issue>
            <fpage>167188</fpage>
            <pub-id pub-id-type="pmid">38657913</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22041.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wilkins</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Agabin</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Varghese</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Talukder</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Gallbladder Dysfunction: Cholecystitis, Choledocholithiasis, Cholangitis, and Biliary Dyskinesia.</article-title>
            <source>Prim Care</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>44</volume>
            <issue>4</issue>
            <fpage>575</fpage>
            <page-range>575-597</page-range>
            <pub-id pub-id-type="pmid">29132521</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22041.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hiwatashi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Okumura</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Setoyama</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ando</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ogura</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Aridome</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Maenohara</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Natsugoe</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Evaluation of laparoscopic cholecystectomy using indocyanine green cholangiography including cholecystitis: A retrospective study.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>2018</year>
            <month>Jul</month>
            <volume>97</volume>
            <issue>30</issue>
            <fpage>e11654</fpage>
            <pub-id pub-id-type="pmid">30045318</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22041.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gallaher</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Charles</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Acute Cholecystitis: A Review.</article-title>
            <source>JAMA</source>
            <year>2022</year>
            <month>Mar</month>
            <day>08</day>
            <volume>327</volume>
            <issue>10</issue>
            <fpage>965</fpage>
            <page-range>965-975</page-range>
            <pub-id pub-id-type="pmid">35258527</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22041.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Han</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>So</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Bang</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Nah</surname>
                <given-names>YW</given-names>
              </name>
            </person-group>
            <article-title>[Surgical Removal of a Huge Common Bile Duct Stone].</article-title>
            <source>Korean J Gastroenterol</source>
            <year>2024</year>
            <month>May</month>
            <day>25</day>
            <volume>83</volume>
            <issue>5</issue>
            <fpage>200</fpage>
            <page-range>200-204</page-range>
            <pub-id pub-id-type="pmid">38783622</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22041.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hirajima</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Koh</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Sakai</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Imamura</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kato</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nishimura</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Soga</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Nishio</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Oguro</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Nakagawa</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Utility of Laparoscopic Subtotal Cholecystectomy with or without Cystic Duct Ligation for Severe Cholecystitis.</article-title>
            <source>Am Surg</source>
            <year>2017</year>
            <month>Nov</month>
            <day>01</day>
            <volume>83</volume>
            <issue>11</issue>
            <fpage>1209</fpage>
            <page-range>1209-1213</page-range>
            <pub-id pub-id-type="pmid">29183521</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22041.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ruhl</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Everhart</surname>
                <given-names>JE</given-names>
              </name>
            </person-group>
            <article-title>Gallstone disease is associated with increased mortality in the United States.</article-title>
            <source>Gastroenterology</source>
            <year>2011</year>
            <month>Feb</month>
            <volume>140</volume>
            <issue>2</issue>
            <fpage>508</fpage>
            <page-range>508-16</page-range>
            <pub-id pub-id-type="pmid">21075109</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22041.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thapar</surname>
                <given-names>VB</given-names>
              </name>
              <name>
                <surname>Thapar</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Goel</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Agarwalla</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Salvi</surname>
                <given-names>PH</given-names>
              </name>
              <name>
                <surname>Nasta</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Mahawar</surname>
                <given-names>K</given-names>
              </name>
              <collab>IAGES Research Collaborative Group</collab>
            </person-group>
            <article-title>Evaluation of 30-day morbidity and mortality of laparoscopic cholecystectomy: a multicenter prospective observational Indian Association of Gastrointestinal Endoscopic Surgeons (IAGES) Study.</article-title>
            <source>Surg Endosc</source>
            <year>2023</year>
            <month>Apr</month>
            <volume>37</volume>
            <issue>4</issue>
            <fpage>2611</fpage>
            <page-range>2611-2625</page-range>
            <pub-id pub-id-type="pmid">36357547</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22041.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nassar</surname>
                <given-names>AHM</given-names>
              </name>
              <name>
                <surname>Khan</surname>
                <given-names>KS</given-names>
              </name>
              <name>
                <surname>Ng</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Sallam</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Operative Difficulty, Morbidity and Mortality Are Unrelated to Obesity in Elective or Emergency Laparoscopic Cholecystectomy and Bile Duct Exploration.</article-title>
            <source>J Gastrointest Surg</source>
            <year>2022</year>
            <month>Sep</month>
            <volume>26</volume>
            <issue>9</issue>
            <fpage>1863</fpage>
            <page-range>1863-1872</page-range>
            <pub-id pub-id-type="pmid">35641812</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22041.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fagenson</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Powers</surname>
                <given-names>BD</given-names>
              </name>
              <name>
                <surname>Zorbas</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Karhadkar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Karachristos</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Di Carlo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lau</surname>
                <given-names>KN</given-names>
              </name>
            </person-group>
            <article-title>Frailty Predicts Morbidity and Mortality After Laparoscopic Cholecystectomy for Acute Cholecystitis: An ACS-NSQIP Cohort Analysis.</article-title>
            <source>J Gastrointest Surg</source>
            <year>2021</year>
            <month>Apr</month>
            <volume>25</volume>
            <issue>4</issue>
            <fpage>932</fpage>
            <page-range>932-940</page-range>
            <pub-id pub-id-type="pmid">32212087</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22041.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fugazzola</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Cobianchi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Di Martino</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tomasoni</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Dal Mas</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Abu-Zidan</surname>
                <given-names>FM</given-names>
              </name>
              <name>
                <surname>Agnoletti</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Ceresoli</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Coccolini</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Di Saverio</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Dominioni</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Far&#x000e8;</surname>
                <given-names>CN</given-names>
              </name>
              <name>
                <surname>Frassini</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gambini</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Lepp&#x000e4;niemi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Maestri</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mart&#x000ed;n-P&#x000e9;rez</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Moore</surname>
                <given-names>EE</given-names>
              </name>
              <name>
                <surname>Musella</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Peitzman</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>de la Hoz Rodr&#x000ed;guez</surname>
                <given-names>&#x000c1;</given-names>
              </name>
              <name>
                <surname>Sargenti</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Sartelli</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Vigan&#x000f2;</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Anderloni</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Biffl</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Catena</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Ansaloni</surname>
                <given-names>L</given-names>
              </name>
              <collab>S.P.Ri.M.A.C.C. Collaborative Group</collab>
            </person-group>
            <article-title>Prediction of morbidity and mortality after early cholecystectomy for acute calculous cholecystitis: results of the S.P.Ri.M.A.C.C. study.</article-title>
            <source>World J Emerg Surg</source>
            <year>2023</year>
            <month>Mar</month>
            <day>18</day>
            <volume>18</volume>
            <issue>1</issue>
            <fpage>20</fpage>
            <pub-id pub-id-type="pmid">36934276</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22041.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Del Vecchio Blanco</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Gesuale</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Varanese</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Monteleone</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Paoluzi</surname>
                <given-names>OA</given-names>
              </name>
            </person-group>
            <article-title>Idiopathic acute pancreatitis: a review on etiology and diagnostic work-up.</article-title>
            <source>Clin J Gastroenterol</source>
            <year>2019</year>
            <month>Dec</month>
            <volume>12</volume>
            <issue>6</issue>
            <fpage>511</fpage>
            <page-range>511-524</page-range>
            <pub-id pub-id-type="pmid">31041651</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22041.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Br&#x000e4;gelmann</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Barahona Ponce</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Marcelain</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Roessler</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Goeppert</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Gallegos</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Colombo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sanhueza</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Morales</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Rivera</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>de Toro</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ortega</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>M&#x000fc;ller</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Gabler</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Scherer</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Waldenberger</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Reischl</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Boekstegers</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Garate-Calderon</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Umu</surname>
                <given-names>SU</given-names>
              </name>
              <name>
                <surname>Rounge</surname>
                <given-names>TB</given-names>
              </name>
              <name>
                <surname>Popanda</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Lorenzo Bermejo</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Epigenome-Wide Analysis of Methylation Changes in the Sequence of Gallstone Disease, Dysplasia, and Gallbladder Cancer.</article-title>
            <source>Hepatology</source>
            <year>2021</year>
            <month>Jun</month>
            <volume>73</volume>
            <issue>6</issue>
            <fpage>2293</fpage>
            <page-range>2293-2310</page-range>
            <pub-id pub-id-type="pmid">33020926</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22041.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sohail</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Shaikh</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Iqbal</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Parkash</surname>
                <given-names>O</given-names>
              </name>
            </person-group>
            <article-title>Acute pancreatitis: A narrative review.</article-title>
            <source>J Pak Med Assoc</source>
            <year>2024</year>
            <month>May</month>
            <volume>74</volume>
            <issue>5</issue>
            <fpage>953</fpage>
            <page-range>953-958</page-range>
            <pub-id pub-id-type="pmid">38783446</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22041.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zaher</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Ebrahim</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Al Salman</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Alchalabi</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Bigger Than a Hen's Egg: A Case of Bouveret Syndrome.</article-title>
            <source>Cureus</source>
            <year>2024</year>
            <month>Apr</month>
            <volume>16</volume>
            <issue>4</issue>
            <fpage>e58742</fpage>
            <pub-id pub-id-type="pmid">38779279</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22041.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Knapik</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Oko&#x00144;</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ulatowska-Bia&#x00142;as</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Fatal pulmonary bile embolism associated with acute pancreatitis - a case report and review of the literature.</article-title>
            <source>Pol J Pathol</source>
            <year>2024</year>
            <volume>75</volume>
            <issue>1</issue>
            <fpage>54</fpage>
            <page-range>54-57</page-range>
            <pub-id pub-id-type="pmid">38741429</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22041.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Field</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Tong</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Cox</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Crichton</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Goodwin</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Welsh</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Cha</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Outcomes of asymptomatic common bile duct stones detected at intraoperative cholangiography.</article-title>
            <source>N Z Med J</source>
            <year>2024</year>
            <month>May</month>
            <day>17</day>
            <volume>137</volume>
            <issue>1595</issue>
            <fpage>73</fpage>
            <page-range>73-79</page-range>
            <pub-id pub-id-type="pmid">38754115</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22041.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Patel</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Kohli</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Savas</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mutha</surname>
                <given-names>PR</given-names>
              </name>
              <name>
                <surname>Zfass</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>TU</given-names>
              </name>
            </person-group>
            <article-title>Surgery Reduces Risk of Complications Even in High-Risk Veterans After Endoscopic Therapy for Biliary Stone Disease.</article-title>
            <source>Dig Dis Sci</source>
            <year>2018</year>
            <month>Mar</month>
            <volume>63</volume>
            <issue>3</issue>
            <fpage>781</fpage>
            <page-range>781-786</page-range>
            <pub-id pub-id-type="pmid">29380173</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22041.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Genser</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Vons</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Can abdominal surgical emergencies be treated in an ambulatory setting?</article-title>
            <source>J Visc Surg</source>
            <year>2015</year>
            <month>Dec</month>
            <volume>152</volume>
            <issue>6 Suppl</issue>
            <fpage>S81</fpage>
            <page-range>S81-9</page-range>
            <pub-id pub-id-type="pmid">26522504</pub-id>
          </element-citation>
        </ref>
        <ref id="article-22041.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Coleman</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Bile duct injuries in laparoscopic cholecystectomy: nursing perspective.</article-title>
            <source>AACN Clin Issues</source>
            <year>1999</year>
            <month>Nov</month>
            <volume>10</volume>
            <issue>4</issue>
            <fpage>442</fpage>
            <page-range>442-54</page-range>
            <pub-id pub-id-type="pmid">10865529</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
